Oncology & Cancer

Most cancer patients believe surgery will be curative

(HealthDay)—Most patients undergoing surgery for lung or colorectal cancer believe that the surgery is likely to be curative, according to a study published in the Oct. 15 issue of Cancer.

Oncology & Cancer

PET/CT imaging of prostate cancer proves accurate biopsy guide

Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of defense, oncologists are considering prostate-specific molecular imaging at the point of initial biopsy ...

Oncology & Cancer

Detecting an early biomarker for pancreatic cancer in blood

Pancreatic ductal adenocarcinoma is one of the most aggressive and deadliest forms of cancer. Treatment options are limited because symptoms typically do not appear until the disease is advanced and complete surgical resection ...

Oncology & Cancer

Improved survival in adult patients with low-grade brain tumors

Using clinical data collected over the past decade through a U.S. cancer registry, researchers at the University of California, San Diego School of Medicine demonstrated that significant strides have been made in improving ...

Oncology & Cancer

Neoadjuvant chemotherapy key to survival in pancreatic cancer

(HealthDay)—Three factors can predict survival in patients with borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 2 in the Annals of ...

Oncology & Cancer

ASCO updates recs on potentially curable pancreatic cancer

(HealthDay)—Guidelines relating to the appropriate adjuvant regimen for patients with pancreatic cancer have been updated in light of new evidence, according to a special article published online April 11 in the Journal ...

Oncology & Cancer

Vessel boost tied to improved surgical resection rate

(HealthDay)—For patients with borderline resectable pancreatic adenocarcinoma (BRPAC) and locally-advanced PAC (LAPAC) treated with neoadjuvant chemoradiation (NACRT), dose escalation with a vessel boost (VB) correlates ...

page 1 from 3